Mechanism and applications of CRISPR/Cas-9-mediated genome editing

M Asmamaw, B Zawdie - Biologics: targets and therapy, 2021 - Taylor & Francis
Clustered regularly interspaced short palindromic repeat (CRISPR) and their associated
protein (Cas-9) is the most effective, efficient, and accurate method of genome editing tool in …

Evolution of CRISPR/cas systems for precise genome editing

M Hryhorowicz, D Lipiński, J Zeyland - International Journal of Molecular …, 2023 - mdpi.com
The bacteria-derived CRISPR/Cas (an acronym for regularly interspaced short palindromic
repeats/CRISPR-associated protein) system is currently the most widely used, versatile, and …

Genome editing in iPSC-based neural systems: from disease models to future therapeutic strategies

A McTague, G Rossignoli, A Ferrini, S Barral… - Frontiers in Genome …, 2021 - frontiersin.org
Therapeutic advances for neurological disorders are challenging due to limited accessibility
of the human central nervous system and incomplete understanding of disease …

Variability in genome editing outcomes: challenges for research reproducibility and clinical safety

L Teboul, Y Herault, S Wells, W Qasim, G Pavlovic - Molecular Therapy, 2020 - cell.com
Genome editing tools have already revolutionized biomedical research and are also
expected to have an important impact in the clinic. However, their extensive use in research …

A Decade of Progress in Gene Targeted Therapeutic Strategies in Duchenne Muscular Dystrophy: A Systematic Review

L Chung Liang, N Sulaiman, MD Yazid - Frontiers in Bioengineering …, 2022 - frontiersin.org
As one of the most severe forms of muscle dystrophy, Duchenne muscular dystrophy (DMD)
results in progressive muscle wasting, ultimately resulting in premature death due to …

[HTML][HTML] Advancements in CRISPR screens for the development of cancer immunotherapy strategies

YR Li, Z Lyu, Y Tian, Y Fang, Y Zhu, Y Chen… - Molecular Therapy …, 2023 - cell.com
CRISPR screen technology enables systematic and scalable interrogation of gene function
by using the CRISPR-Cas9 system to perturb gene expression. In the field of cancer …

[HTML][HTML] Molecular and Biochemical Therapeutic Strategies for Duchenne Muscular Dystrophy

L Krishna, A Prashant, YH Kumar, S Paneyala… - Neurology …, 2024 - mdpi.com
Significant progress has been achieved in understanding Duchenne muscular dystrophy
(DMD) mechanisms and developing treatments to slow disease progression. This review …

Electron microscopic analysis of the influence of iPSC-derived motor neurons on bioengineered human skeletal muscle tissues

CT Nguyen, C Chávez-Madero, E Jacques… - Cell and Tissue …, 2024 - Springer
Abstract 3D bioengineered skeletal muscle macrotissues are increasingly important for
studies of cell biology and development of therapeutics. Tissues derived from immortalized …

CRISPR-CAS9 GENE EDITING IN PHARMACEUTICALS: CURRENT APPLICATIONS AND FUTURE PROSPECTS.

KJ Mangala, SA Baig, S Gugulothu… - … & Cellular Archives, 2023 - search.ebscohost.com
CRISPR-Cas9 gene editing has emerged as a transformative tool in pharmaceuticals,
revolutionizing the understanding and treatment of genetic diseases. This review explores …

Gene Therapies for Spinal Muscular Atrophy and Duchenne Muscular Dystrophy: A Pathbreaking Moment in Therapeutics

SK Srinivasamurthy, W Fatima… - Journal of …, 2022 - classical.goforpromo.com
Background: Gene therapy has proved to be a boon for neuromuscular diseases. A concept
introduced in the early 1960's, has been put into clinical practice in the past 5-10 years. The …